The non fusion spinal devices market is expected to be valued at USD 4.37 billion in 2023. The market is projected to rise at a CAGR of 4.8% from 2023 to 2033, to attain a market value of USD 6.99 billion by 2033.
The global demand for non fusion spinal devices is driven by:
The non fusion spinal devices market is witnessing an upsurge because of the rising prevalence of spinal disorders, such as spinal stenosis and degenerative disc disease.
Spinal implants are used to provide stability and invigorate the spine of patients, in addition, to treating disproportion of the spine. These devices are broadly segmented as fusion and non-fusion spinal devices. Integration of non-fusion technologies into spinal surgery has improved outcomes by providing patients with at least some movements and flexibility in the spine.
The demand for non-fusion spinal devices mainly originates from patients who are suffering from the problem of gradual disc damage. Degenerative disc disease often results in disc herniation, and chronic back or neck pain.
As per WHO, back pain impacts all people, irrespective of their age, from children to the elderly, and is a recurrent factor behind medical consultations. It is hard to guesstimate the incidence of back pain, as its occurrence is already quite high by the time a person reaches adulthood, and the symptoms are liable to recur over time. In industrialized countries, the lifetime pervasiveness of non-specific (common) back pain is projected to be 60% to 70%.
Aggressive operations, along with technological advancement, are pushing the adoption of non-fusion spinal devices. Furthermore, issues such as heart attack and obesity that are being brought upon by the swelling geriatric population and lifestyle problems, are boosting the global demand for non-fusion spinal devices.
Increasing cases of spinal illnesses, such as degenerative disc disease, as well as an aging population, are propelling the global demand further for non-fusion spinal devices forward, particularly in the United States and Europe.
| Report Attribute | Details |
|---|---|
| Estimated Base Year Value (2023) | USD 4.37 billion |
| Projected Growth Rate (2023 to 2033) | 4.8% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The non-fusion spinal devices market is maneuvered by the ongoing technological advances and release of the latest iterations of treatment products. Many companies leading in spine innovation, to improve patients’ quality of life, are delivering comprehensive biologics, cervical, and thoracolumbar solutions, navigation, and robotics technologies. The key participants are also offering training as well as clinical support to surgeons.
By providing innovative spine products, leading companies are enabling outcome-centered and clinically-proven designs, and anatomically-comprehensive treatments ranging from sacrum to occipital-cervical-thoracic. These devices also enable the possibility of diverse treatment philosophies, such as minimally invasive procedures.
Further, technological advances such as 3D printed titanium and VerteBRIDGE® in the spine products have boosted the relevance of the wide patient population and spine pathologies like adolescent deformity, aging degenerative discs, and active motion preservation.
With rapid technological advancement and wide acceptance of non-fusion spinal technologies and disc diagnostic devices among patients with back pain problems, the global non-fusion spinal devices market is expected to hold a 4.8% CAGR in the forecast period.
The market is estimated to attain a market value of USD 4.37 billion by 2023. Over the historical period, the non-fusion spinal devices industry has been positively influenced by several factors, such as the surging adoption of minimally invasive spinal surgeries, new technological advances in the spinal surgery sector, the rising obese population, and degenerative spinal conditions.
By 2033, the market is estimated to attain USD 6.99 billion, expanding at a CAGR of 4.8% in the forecast period. Future Market Insights examines upcoming trends against the given time duration:
| Year | Expected Valuation |
|---|---|
| 2025 | USD 4.80 billion |
| 2028 | USD 5.52 billion |
| 2032 | USD 6.66 billion |
Principal Consultant
The dynamic stabilization devices segment is projected to account for a significant market percentage over the forecast period. These devices comprise pedicle screw-based systems, facet replacement products, and interspinous process spacers.
The segment growth can be ascribed to the utilization of rigid spinal implants due to their fusion technologies. Additionally, the ongoing transformation in therapeutic procedures owing to technological innovations, such as the adoption of BioFlex systems and improvements in biochemical, is projected to facilitate segment development.
The adoption of dynamic stabilization devices is projected to be fueled by the increasing cases of lumbar disc herniation, which results in the lower back as well as radicular leg pain. These devices assist in the treatment of lumbar degenerative diseases.
The hospital segment is expected to significantly contribute to the market growth. The growth of this segment can be credited to the easy access to advanced healthcare infrastructure in the developed regions, in addition to the growing demand for high-quality healthcare services.
The availability of skilled surgeons and numerous healthcare providers at hospitals ensures intensive care throughout and post the surgery, disparate from other surgical centers. Thus, boosting the expansion of this segment.
The orthopedic center segment is anticipated to expand at a significant rate in the coming years. The robust growth of this segment can be attributed to the emerging field of spine surgery that includes orthopedic surgeons specialized in spine surgeries.
The non fusion spinal devices market players are vigorously responding to the increasing demand for non-fusion spinal devices by developing new, more advanced products.
Additionally, the market participants are employing various tactics, such as acquisitions, mergers, product upgradation, etc., to strengthen their hold over the market. The high demand for these devices is pushing key players to make proactive decisions to rise above the existing market rivalry.
Latest developments
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Attributes | Details |
|---|---|
| Forecast Period | 2023 to 2033 |
| Historical Data Available for | 2018 to 2022 |
| Market Analysis | USD million/ billion for Value |
| By Product | Artificial Disc Replacement Device, Partial Disc (Nucleus) Replacement Device, Dynamic Stabilization Devices, Total Facet Replacement Devices, Annulus Repair Device,Others |
| By End User | Hospitals, Orthopedic Centers, Others |
| By Region | North America; Latin America; Europe; Asia Pacific; The Middle East and Africa |
| Key Players | Zimmer Biomet; Medtronic; Medical Device Business Services, Inc.; Stryker; Others |
The non fusion spinal devices market CAGR for 2033 is 4.8%.
The market is estimated to reach USD 6.99 billion by 2033.
Key players in the non fusion spinal devices market are developing it by introducing innovative products.
The market is estimated to secure a valuation of USD 4.37 billion in 2023.
Medtronic, Zimmer Biomet, and NuVasive are the key non fusion spinal devices market players.
1. Executive Summary 2. Market Overview 3. Market Background 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type 5.1. Artificial Disc Replacement Device 5.2. Partial Disc (Nucleus) Replacement Device 5.3. Dynamic Stabilization Devices 5.4. Annulus Repair Devices 5.5. Total Facet Replacement Device 5.6. Others 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End User 6.1. Hospitals 6.2. Orthopaedic Centres 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 7.1. North America 7.2. Latin America 7.3. Europe 7.4. Asia Pacific 7.5. MEA 8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11. Asia Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13. Key Countries Market Analysis 14. Market Structure Analysis 15. Competition Analysis 15.1. B Braun Melsungen 15.2. Centinel Spine LLC 15.3. Johnson & Johnson 15.4. Medtronic PLC 15.5. Pioneer Surgical Technologies 15.6. Stryker Corporation 15.7. Zimmer Holdings Inc. 15.8. RTI Surgical Holdings Inc. 15.9. NuVasive Inc. 15.10. Paradigm Spine 16. Assumptions & Acronyms Used 17. Research Methodology
Explore Healthcare Insights
View Reports
Non Fusion Spinal Devices Market
